Tirzepatide · 5 mg
Published- batch · LOT
- B-2026-TIRZ-5-001
- Laboratory
- Janoshik
- purity
- 99.98%
- Test date
- 25.10.2026
Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
A weight-control peptide: acts on two hormones at once — GIP and GLP-1, injected once a week. Appetite drops noticeably, and in studies it reduced weight more on average than semaglutide.
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (weeks 1–4) | 2.5 mg weekly | Starting dose |
| Titration | 5 → 7.5 → 10 → 12.5 mg weekly | +2.5 mg every 4 weeks if needed |
| Maximum | 15 mg weekly | Maximum in this schedule |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Nausea, diarrhea, vomiting | Adults with type 2 diabetes, 40 weeks, versus placebo | Nausea 12-18% vs 6%, diarrhea 12-14% vs 8%, vomiting 2-6% vs 2% | [3] |
| Nausea, diarrhea, vomiting | Adults with type 2 diabetes; tirzepatide 5, 10 or 15 mg versus semaglutide 1 mg; 40 weeks | Nausea 17-22% vs 18%, diarrhea 13-16% vs 12%, vomiting 6-10% vs 8% | [4] |
| Nausea, diarrhea, decreased appetite, vomiting | Type 2 diabetes with increased cardiovascular risk, versus insulin glargine, full study period, 52 to 104 weeks | Nausea 12-23%, diarrhea 13-22%, decreased appetite 9-11%, vomiting 5-9%; glargine 2%, 4%, under 1% and 2% | [5] |
FAQ
Find answers to questions about Tirzepatide and related materials.
Tirzepatide is supplied as a lyophilized powder, which ensures molecular stability during storage and ease of reconstitution.
Source / documentationTirzepatide comes in three package sizes: 5 mg, 30 mg, and 120 mg. Pick the one you need in the size selector above.
Source / documentationBatches of Tirzepatide are tested by independent third-party laboratories, and we publish the reports in the open COA archive. Check the current list of reports for this substance at /coa?q=tirzepatide to see which batches already have a published certificate.
Source / documentationThe reconstituted solution should be stored at 2–8 °C. Detailed storage conditions and shelf-life after reconstitution are provided on the label and in the LOT technical documentation.
Source / documentationRUO means the product is intended exclusively for scientific research in laboratory settings. Tirzepatide from Longeva is not a medicine and is not permitted for clinical use or human application.
Source / documentationTirzepatide is a research molecule, a synthetic dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. For a full breakdown of the receptors, mechanism, and weekly profile, see the wiki reference: /wiki/tirzepatide.
Source / documentationNo. Tirzepatide from Longeva is a research molecule, not a brand name. It is neither Mounjaro (a pharmaceutical drug) nor Zepbound (a brand name), but a pure research sample for laboratory purposes.
Source / documentationA sealed lyophilized vial is stored at -20 °C, protected from light and moisture: in that state the dry powder is stable for months to years. That differs from storing the already reconstituted solution (2–8 °C, a few weeks). See the full storage and lab-handling breakdown on the documentation page /en/docs/tirzepatide.
Source / documentationIt is a peptide for weight and blood-sugar control that copies two hormones at once — GIP and GLP-1. Both strengthen fullness and help control sugar, so tirzepatide is used for weight loss and in type 2 diabetes. It is injected once a week.
Source / documentationThe powder is dissolved with bacteriostatic water and injected under the skin once a week — into the abdomen, thigh or upper arm, rotating the spot a little each time. You start at 2.5 mg and raise it by 2.5 mg every 4 weeks, up to the schedule maximum of 15 mg. The full schedule is in the dosing guide on this page.
Source / documentationLet the vial warm to room temperature, then slowly add bacteriostatic water with a syringe down the vial wall. Swirl the vial gently in your hands until the powder dissolves; never shake it. The amount of water depends on the vial size and the concentration you need — a worked example for your schedule is in the preparation guide on this page.
Source / documentationTirzepatide acts on two receptors (GIP and GLP-1), semaglutide on one (GLP-1), and in studies tirzepatide on average produced greater weight loss. Semaglutide has been on the market longer and is often gentler at the start. A detailed comparison is in the "tirzepatide or semaglutide" article linked from the description.
Source / documentationThe most common are nausea, sometimes vomiting, diarrhea or constipation, especially at the start and when the dose goes up — which is why it is raised slowly, by 2.5 mg every 4 weeks. The full safety profile, including rare serious risks, is covered in the tirzepatide monograph in our wiki.
Source / documentationThe price depends on the pack size — current prices and stock are shown in the product card on this page. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentationThere is no direct ban in the studies, but alcohol adds calories and can worsen nausea and blood-sugar swings, so people usually limit it during a course. If you drink, avoid an empty stomach and the injection day.
Source / documentationThe half-life of tirzepatide is approximately 5 days. The figure is stated in both the FDA and EMA labels; a population pharmacokinetic analysis across 5,802 participants gives a half-life of 5.4 days. See the Dosing section for detail.
Source / documentationCertificates shown: 3
Selected size: 5 mg
5 mg analysis published
Research, properties and limitations
AI can make mistakes
1 review
Беру постоянно тут работает, фото не могу приложуть а то баг на сайте, исправлю как пройдет
Tirzepatide is a peptide for weight and blood-sugar control that acts on two hormones at once. Most drugs in this class copy one hormone — GLP-1, which tells the pancreas to release insulin and the brain that we are full. Tirzepatide also works like a second hormone, GIP, which also takes part in sugar and fat metabolism. Two signals together give a stronger effect than one.
What it does: in the SURMOUNT programme tirzepatide was studied for weight control, and in SURPASS for blood-sugar control in type 2 diabetes. In studies it on average produced greater weight loss than semaglutide, which works through GLP-1 only; how those studies were designed is covered in our SURPASS and SURMOUNT review, and the two molecules are compared head-on in our tirzepatide vs semaglutide article.
How it is used: the vial holds a dry powder (lyophilisate). It is dissolved with bacteriostatic water and injected under the skin once a week. You start at 2.5 mg and raise it by 2.5 mg every 4 weeks: 5 → 7.5 → 10 → 12.5 → 15 mg. The slow ramp-up helps keep nausea down. The exact schedule is in the dosing guide on this page.
Brands: the same molecule is sold worldwide as Eli Lilly's finished medicines — Mounjaro (for diabetes) and Zepbound (for weight). We sell the molecule itself, not a brand; the difference is explained in our Mounjaro article. Next on the shelf are the semaglutide brands (our Ozempic article) and the daily liraglutide (brand Saxenda, its own article).
Batch and COA: every batch is tested by independent laboratories. Find the LOT number on your vial and open the certificate of analysis (COA) for that exact batch in our open COA archive. Typical purity is 98–99%.
Comparison: tirzepatide works on two receptors, semaglutide on one, and retatrutide on three (GIP, GLP-1 and glucagon) — but retatrutide is still experimental. The full line is in the GLP-1 peptides category on the site.
Documentation and storage: batch details and storage conditions are kept on the documentation page. In short: dry powder in a dry, dark place at a low temperature; once dissolved, in the refrigerator. The scientific details — molecular structure and pharmacology — are in our wiki article on tirzepatide.
Buy 2, get the 3rd free
The set contains two vials of 120 mg.
240 mg: Best value · Save ≈ $84.86